This inventor holds 0 USPTO granted patents, plus 6 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Alexander B Baguisi: Innovator in Ischemic Injury Treatment
Introduction
Alexander B Baguisi is a notable inventor based in the United States, recognized for his contributions to the field of medical treatments for ischemic injuries. His innovative work focuses on developing compounds that can effectively address ischemia and ischemia-reperfusion injuries.
Latest Patents
Although Alexander B Baguisi currently holds no patents, he has been involved in significant inventions. His latest patents include "Lipoyl Compounds And Their Use For Treating Ischemic Injury," which relates to compounds represented by Structural Formula (I) and their use in treating ischemic conditions. Another notable invention is "Use Of N-(R)-Lipoyl-L-Glutamyl-L-Alanine In The Treatment Of Ischemic And Ischemia-Reperfusion Injuries," which discusses methods for activating cytoprotective kinases to treat ischemic injuries.
Career Highlights
Alexander B Baguisi works at Ischemix, LLC, where he focuses on developing innovative solutions for ischemic injury treatment. His work is pivotal in advancing medical therapies that can improve patient outcomes in critical situations.
Collaborations
He collaborates with esteemed colleagues, including Reinier Beeuwkes and Ralph Casale, to further enhance the research and development of effective treatments for ischemic injuries.
Conclusion
Alexander B Baguisi is a dedicated inventor whose work in ischemic injury treatment showcases his commitment to medical innovation. His contributions are vital in the ongoing quest to improve therapeutic options for patients suffering from ischemic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile